Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2878-2882
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2878
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2878
Table 1 Pre-TACE plasma VEGF levels in patients categorized by radiological parameters
Group | No. of patients | Median plasma VEGF (ng/L) | Statistic value | P value | |
Cirrhotic liver | No | 13 | 80.15 | t = 1.380 | 0.175 |
Yes | 32 | 57.19 | |||
Tumor location | Left lobe | 4 | 77.82 | F = 0.275 | 0.843 |
Right lobe | 26 | 66.62 | |||
Spiegel’s lobe | 5 | 50.38 | |||
Multiple lobe | 10 | 57.68 | |||
Tumor capsule | No | 32 | 68.15 | t = 0.888 | 0.379 |
Yes | 13 | 53.18 | |||
Ascites | No | 37 | 62.81 | t = 1.151 | 0.280 |
Yes | 8 | 82.60 | |||
Lymph node involvement | No | 39 | 61.68 | t = 1.677 | 0.101 |
Yes | 6 | 101.31 | |||
Tumor vascularity | Hypervascularity | 31 | 75.59 | F = 0.922 | 0.406 |
Median | 9 | 55.31 | |||
Hypovascularity | 3 | 39.1 | |||
Tumor size | < 5 cm | 7 | 27.57 | F = 5.804 | 0.006 |
5-10 cm | 22 | 55.59 | |||
> 10 cm | 11 | 101.54 | |||
Portal vein thrombosis | No | 37 | 57.97 | t = 2.669 | 0.011 |
Yes | 8 | 104.79 | |||
Extra hepatic metastasis | No | 39 | 59.39 | t = 2.483 | 0.017 |
Yes | 6 | 116.18 | |||
TNM classification | Stage II | 16 | 36.55 | F = 2.937 | 0.044 |
Stage III | 12 | 71.23 | |||
Stage IVa | 11 | 79.72 | |||
Stage IVb | 6 | 92.63 | |||
Arterio-portal vein shunting | No | 37 | 56.03 | t = 2.283 | 0.026 |
Yes | 8 | 99.9 |
Table 2 Effect of different VEGF levels on specificity and sensitivity in predicting tumor load in patients with HCC
Cut-off VEGF | Sensitivity | Specificity | Positive | Negative predictive | |
value (ng/L) | (%) | (%) | predictive value (%) | value (%) | |
T II and T III/IV | 36.55 | 75.9 | 62.5 | 78.6 | 58.8 |
Portal vein thrombosis | 57.97 | 62.5 | 64.9 | 27.8 | 88.8 |
Extra hepatic metastasis | 59.39 | 50 | 64.1 | 17.6 | 89.3 |
Arterio-portal vein shunting | 56.03 | 75 | 67.6 | 33.3 | 92.6 |
Table 3 Correlation between plasma VEGF concentration and response to treatment
Clinical response | Plasma VEGF (ng/L) | No. of patients | |||
Low VEGF | High VEGF | ||||
Responder | 49.52 ± 25.33 | t = 2.285 | 16 | 2 | χ2 = 5.599 |
Non-responder | 73.33 ± 70.32 | P = 0.025 | 15 | 12 | P = 0.018 |
- Citation: Li X, Feng GS, Zheng CS, Zhuo CK, Liu X. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level. World J Gastroenterol 2004; 10(19): 2878-2882
- URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2878.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2878